BioSpace News Archive

Finding Balance in Chaotic and Stressful Circumstances is not easy for anyone. However, according to a public health research study published today in the Scientific Reports, even during the most stressful situations, the Tamarkoz method of meditation is a scientifically sound solution.

Ischemia Care announced a new program called “CLASSICS,” which stands for Clinical Laboratory and Strategic Support to Identify Stroke and Cause of Stroke to commercialize a portfolio of hospital-based blood tests across industry leading laboratory platforms for ischemic stroke and underlying causes used in the hospital setting.

The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, announced the 2021 class of Harrington Scholar-Innovators.

According to The Insight Partners market research study titled ‘Durable Medical Equipment Market to 2027 – Global Analysis and Forecasts by Device Type, End User, and Geography.’ The global durable medical equipment market is expected to reach US$ 291.53 Bn in 2027 from US$ 170.89 Bn in 2018.

The peptide therapeutics market was valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027; it is expected to grow at a CAGR of 9.2% from 2020 to 2027.

NeurOptics, the worldwide leader in the science of pupillometry, announced the U.S. launch of its NPi®-300, a next-generation automated pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, guiding treatment and informing prognosis for clinicians and their patients.

Rising prevalence of cardiovascular diseases and surging demand for third-party IVD quality control products are expected to spur market growth.

The Melanoma Research Alliance, the largest non-profit funder of melanoma research, is proud to announce its 2021 Dermatology Fellowship Award recipients.

Former COVID-19 patients may benefit from additional clinical support, including tailored physical and mental health rehabilitation services, according to a study released by The Centers for Disease Control and Prevention in collaboration with Select Medical.

As one of the first commercial labs to deliver COVID-19 testing, Eurofins Viracor, Inc. continues to innovate with the launch of Coronavirus SARS-CoV-2 inSIGHT™ T Cell Immunity testing.